Association of Calnexin with Wild Type and Mutant AVPR2 that Cause Nephrogenic Diabetes Insipidus
- 12 May 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 40 (23) , 6766-6775
Abstract
Over 155 mutations within the V2 vasopressin receptor (AVPR2) gene are responsible for nephrogenic diabetes insipidus (NDI). The expression and subcellular distribution of four of these was investigated in transfected cells. These include a point mutation in the seventh transmembrane domain (S315R), a frameshift mutation in the third intracellular loop (804delG), and two nonsense mutations that code for AVPR2 truncated within the first cytoplasmic loop (W71X) and in the proximal portion of the carboxyl tail (R337X). RT-PCR revealed that mRNA was produced for all mutant receptor constructs. However, no receptor protein, as assessed by Western blot analysis, was detected for 804delG. The S315R was properly processed through the Golgi and targeted to the plasma membrane but lacked any detectable AVP binding or signaling. Thus, this mutation induces a conformational change that is compatible with endoplasmic reticulum (ER) export but dramatically affects hormone recognition. In contrast, the W71X and R337X AVPR2 were retained inside the cell as determined by immunofluorescence. Confocal microscopy revealed that they were both retained in the ER. To determine if calnexin could be involved, its interaction with the AVPR2 was assessed. Sequential coimmunoprecipitation demonstrated that calnexin associated with the precursor forms of both wild-type (WT) and mutant receptors in agreement with its general role in protein folding. Moreover, its association with the ER-retained R337X mutant was found to be longer than with the WT receptor suggesting that this molecular chaperone also plays a role in quality control and ER retention of misfolded G protein-coupled receptors.Keywords
This publication has 17 references indexed in Scilit:
- Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidusMolecular and Cellular Endocrinology, 2000
- Corrigendum to: The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residuesFEBS Letters, 2000
- Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutantsJournal of Clinical Investigation, 2000
- Misfolding of Mutant Aquaporin-2 Water Channels in Nephrogenic Diabetes InsipidusJournal of Biological Chemistry, 1999
- The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activitiesFEBS Letters, 1998
- Folding of Secretory and Membrane ProteinsNew England Journal of Medicine, 1998
- Phosphorylation of the V2 Vasopressin ReceptorJournal of Biological Chemistry, 1997
- Functional characterization of five V2 vasopressin receptor gene mutationsMolecular and Cellular Endocrinology, 1996
- Membrane Targeting and Determination of Transmembrane Topology of the Human Vasopressin V2 ReceptorJournal of Biological Chemistry, 1996
- Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus.Journal of Clinical Investigation, 1995